Sanguinity Health

Sanguinity Health appears to be a healthcare-focused consulting and commercialization services company rather than a therapeutics developer. Public references identify Laura Randa as CEO and President of Sanguinity Health in 2021, and her commentary described the company’s opportunity in digital healthcare and digital therapeutics. Available evidence suggests Sanguinity Health operated in the broader healthcare and life sciences market access, reimbursement, and medtech/pharma commercial strategy ecosystem. I could not find evidence of a proprietary drug pipeline, clinical-stage assets, or regulated therapeutic products. The company therefore appears best characterized as a commercial-stage healthcare services business with limited publicly available corporate detail.